title: [Recent progress of BMSCs acting as seeding cell for tissue engineered cartilage].
abstract: OBJECTIVE
  To review the recent progress of BMSCs acting as seeding cell for tissue engineered cartilage.
  
  
  METHODS
  The recent ten years literature about BMSCs acting as seeding cell for tissue engineered cartilage was extensively reviewed.
  
  
  RESULTS
  Scaffold provided an optimal environment for the growth of BMSCs. Cytokine and gene delivery could promote BMSCs to differentiate toward chondrocytes. All of them played important roles in the field of cartilage tissue engineering.
  
  
  CONCLUSIONS
  The improvement of three-dimensional scaffolds, the rational use of cytokine, and the enhancement of gene delivery will promote the development of clinical cartilage reconstruction.
authors: Department of Plastic Surgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou Guangdong, 510080, P.R. China.
authors: Shuqia
authors: S
authors: Xu
authors: Yangbin
authors: Y
authors: Xu
mesh_terms: D000818:Animals; D001672:Biocompatible Materials; D001854:Bone Marrow Cells / Q000166:cytology*; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000494:pharmacology; D002356:Cartilage; D018929:Cell Culture Techniques / Q000379:methods; D002454:Cell Differentiation; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology; D016207:Cytokines / Q000235:genetics / Q000494:pharmacology*; D005109:Extracellular Matrix; D006801:Humans; D011817:Rabbits; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds; D014162:Transfection; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000494:pharmacology
chemical_list: D001672:Biocompatible Materials; D019485:Bone Morphogenetic Proteins; D016207:Cytokines; D016212:Transforming Growth Factor beta